Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD

Completed · Phase 3

Conditions studied: ADHD

In brief

The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD.

Key facts

Study ID

NCT00141063

Run by

Novartis

People needed

90

Starts

2005-06-01

Expected to finish

2005-08-01

Last updated by the study team

2007-12-21

Who can join

Age: 6 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• DSM-IV diagnosis of ADHD
• Males and females aged 6-12

You may not qualify if…

• Inability of understand or follow instructions
• Is pregnant
• Diagnosis of tic disorder
• History of seizure disorder

Where it is running

• Center for Psychiatry & Behavioral Medicine — Las Vegas, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.